Zephyr Valve Japan Post-Marketing Surveillance

RecruitingOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

March 12, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2028

Conditions
EmphysemaCOPDSevere Emphysema
Interventions
DEVICE

Zephyr Endobronchial Valve

Zephyr Valve provides an alternative technique to achieve bronchoscopic lung volume reduction (BLVR) using a minimally invasive approach. Zephyr Valve is a tiny unidirectional valve. During BLVR, multiple valves are placed to occlude a hyperinflated lobe of the lungs, allowing air to escape while blocking airflow into the treated lobe. This is intended to result in a reduction in lung volume and hyperinflation in the targeted area. Consequently, the remaining lobes can expand more fully, the overall lung works more efficiently, with resultant improvement in overall lung function in patients with hyperinflation associated with severe emphysema.

Trial Locations (17)

Unknown

RECRUITING

Tosei General Hospital, Aichi

RECRUITING

Gifu Prefectural Medical Center, Gifu

RECRUITING

Kanagawa Cardio Chest Center, Kanagawa

RECRUITING

Kanazawa University Hospital, Kanazawa

RECRUITING

St Marianna University Hospital, Kawasaki

RECRUITING

Matsusaka Civic Hospital, Mie

RECRUITING

Nagasaki University Hospital, Nagasaki

RECRUITING

Nagoya Medical Center, Nagoya

RECRUITING

Okayama Medical Center, Okayama

RECRUITING

Kinki Chuo Chest Medical Center, Osaka

RECRUITING

Hokkaido University Hospital, Sapporo

RECRUITING

Tohoku University Hospital, Sendai

RECRUITING

Shiga University Hospital, Shiga

RECRUITING

Tokyo National Hospital, Tokyo

RECRUITING

Fujita Health University Hospital, Toyoake

NOT_YET_RECRUITING

Dokkyo University Hospital (Pulmonary Medicine and Clinical Immunology), Utsunomiya

RECRUITING

Dokkyo University Hospital, Utsunomiya

All Listed Sponsors
lead

Pulmonx Corporation

INDUSTRY